The Enterprise Value as of November 2025 (TTM) for Selecta Biosciences, Inc. (SELB) is -11774246.00

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -11774246.00. This represents a change of -87.88% compared to the average of -97166385.25 of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical Enterprise Value (quarterly & annually)

How has SELB Enterprise Value performed in the past?

The mean historical Enterprise Value of Selecta Biosciences, Inc. over the last ten years is 119.49M. The current -11774246.00 Enterprise Value has changed -1085.41% with respect to the historical average. Over the past ten years (40 quarters), SELB's Enterprise Value was at its highest in in the March 2021 quarter at 411.06M. The Enterprise Value was at its lowest in in the June 2025 quarter at -129638371.17.

Selecta Biosciences, Inc. (SELB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Selecta Biosciences, Inc. (SELB) Average Enterprise Value

How has SELB Enterprise Value performed in the past?

The current Enterprise Value of Selecta Biosciences, Inc. (SELB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Selecta Biosciences, Inc. (SELB) Enterprise Value vs. Peers

How is SELB’s Enterprise Value compared to its peers?

Selecta Biosciences, Inc.’s Enterprise Value is less than Pardes Biosciences, Inc. (75.90M), less than aTyr Pharma, Inc. (87.32M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than NGM Biopharmaceuticals, Inc. (69.72M), less than Decibel Therapeutics, Inc. (102.82M), less than Sesen Bio, Inc. (127.66M), less than Kinnate Biopharma Inc. (71.17M), greater than Cyteir Therapeutics, Inc. (-37516738.00), less than F-star Therapeutics, Inc. (91.20M), less than Opiant Pharmaceuticals, Inc. (88.02M),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.